I have followed Cannabis Science Inc. (CBIS) for quite some time. I found their news release published yesterday a bit disturbing. They are suggesting that their product – medical marijuana – could cure cancer based on some photos from four patients. Yes, you go to their front page and you see FOUR such links. Anyone that knows about medical research knows these are anecdotal stories (See Wikipedia on Anecdotal Evidence).
Don’t take this as knocking CBIS. I share further down reasons why I know the product is valid and had a real medical purpose. I just don’t like this suggestion.
Remember that guy that ran Apple. What was his name? Oh, yes, Steve Jobs.
Now, Steve was a smart guy. Likely the most brilliant of his time. This is a different form of cancer, and the prescribed treatment was different. But – this is what happens when one says “screw the statistics, I am going to follow another medical path.” Nobody can say that Steve would be around now had he followed more conventional advice, but his cancer was among the most curable. This article (FOUND HERE) has a bias, and that bias is against alternatives.
This paragraph is from yesterday’s press release:
“Cannabis Science continues to focus on cancer as a major initial target for treatment with its critical ailment formulations. Cannabis Science has provided the scientific foundation for numerous patients suffering from cancer to make the informed decision to treat themselves with cannabis extracts. The company has seen vast improvement in four out of patients with skin cancer to date who we have been scientifically advising. Their photo-documentation is available on the Cannabis Science website www.cannabisscience.com and click on the breaking news button where you will find all the cancer related and updated patient news.”
They are seriously suggesting this as a treatment for cancer.
You know the FDA will eventually see this. Why would they put out such a suggestion?
Okay – finance a study. Do it the right way. If they believe in it so much as a cure for skin cancer, do not make suggestions on the web site and in press releases that it cures cancer. Get a real study going and do it the right way. Of course they cannot and will not. It is not like they own a patent on medical marijuana. They are just trying to move product or shares, or both.
I am not against the products that CBIS has to offer. My thought is that these products should be used in conjunction with conventional treatments, not as a replacement. Having had a mother go through many rounds of chemotherapy in the 1990’s, I know she would have been better off with the product as nausea leads to weight loss. Massive weight loss leads to death. She died shortly after being weighed in at just 77 pounds at her last doctors visit.
Great product. The cure stuff needs to go. People will believe such anecdotal accounts all the way to the grave.
Want to see the “evidence” on the CBIS site? I am not going to put these ugly pictures in this piece, but you can certainly link to the PDF document that CBIS is linking off to: SEE IT HERE
Related Posts on StockGuru.com:
[rss feed=”http://stockguru.com//tag/cbis/feed/” num=”15″ excerpt=”false” target=”]
About the StockGuru Leader Board:
We watch for stocks moving up and creating a positive momentum in the market. We are not compensated for coverage.
Feel free to suggest a stock for coverage if you see it breaking out. Contact: [email protected].
StockGuru.com
StockGuruCanada.com
Shareholdervision.com
BoldStocks.com
IR Affiliates – IRIR.co
StoneBridge Web & SEO – StonebridgeIQ.com
All content on StockGuru.com is original content – with the exception of client news releases. All content is (C) Copyright 2002 to 2012 StockGuru. No content may be used in whole or in part without the express written consent of our Publisher. We encourage web sites interested in our content to offer a reciprocal exchange agreement in exchange for use of some of our content. We do not offer advance approval, but contact our Publisher if you have an interest in repropagating our content. Contact as at: [email protected] or (469) 252-3030. Mailing address: 1601 Berwick Drive; McKinney, Texas 75070